Competitive Density
Active trials by therapeutic area and indication
Density Legend (based on active Phase 3 trials & sponsor count)
Hot (crowded)
Warm (competitive)
Cool (moderate)
Cold (sparse)
Oncology
22187 active trialsSolid Tumor (Advanced)
Ph3: 330 • Ph2: 1748 • 15 sponsors
Breast Cancer
Ph3: 296 • Ph2: 858 • 15 sponsors
NSCLC
Ph3: 268 • Ph2: 875 • 15 sponsors
Colorectal Cancer
Ph3: 177 • Ph2: 714 • 15 sponsors
Non-Hodgkin Lymphoma
Ph3: 163 • Ph2: 944 • 15 sponsors
ALL
Ph3: 152 • Ph2: 620 • 15 sponsors
Prostate Cancer
Ph3: 152 • Ph2: 538 • 15 sponsors
Multiple Myeloma
Ph3: 104 • Ph2: 397 • 15 sponsors
Hepatocellular Carcinoma
Ph3: 92 • Ph2: 379 • 15 sponsors
Bladder Cancer
Ph3: 85 • Ph2: 272 • 15 sponsors
Esophageal Cancer
Ph3: 81 • Ph2: 299 • 15 sponsors
Gastric Cancer
Ph3: 80 • Ph2: 319 • 15 sponsors
AML
Ph3: 75 • Ph2: 352 • 15 sponsors
Lung Cancer (General)
Ph3: 75 • Ph2: 343 • 15 sponsors
Ovarian Cancer
Ph3: 74 • Ph2: 293 • 15 sponsors
Pancreatic Cancer
Ph3: 71 • Ph2: 413 • 15 sponsors
Melanoma
Ph3: 59 • Ph2: 300 • 15 sponsors
Hematologic Malignancies
Ph3: 55 • Ph2: 311 • 15 sponsors
SCLC
Ph3: 54 • Ph2: 195 • 15 sponsors
Head and Neck Cancer
Ph3: 51 • Ph2: 334 • 15 sponsors
Cervical Cancer
Ph3: 45 • Ph2: 179 • 15 sponsors
Neuroendocrine Tumors
Ph3: 45 • Ph2: 115 • 15 sponsors
Sarcoma
Ph3: 41 • Ph2: 326 • 15 sponsors
Triple Negative Breast Cancer
Ph3: 39 • Ph2: 206 • 15 sponsors
Brain Tumor
Ph3: 37 • Ph2: 171 • 15 sponsors
CLL
Ph3: 35 • Ph2: 136 • 15 sponsors
Renal Cell Carcinoma
Ph3: 33 • Ph2: 168 • 15 sponsors
Squamous Cell Carcinoma
Ph3: 33 • Ph2: 227 • 15 sponsors
MDS
Ph3: 32 • Ph2: 221 • 15 sponsors
Endometrial Cancer
Ph3: 32 • Ph2: 136 • 15 sponsors
Glioblastoma
Ph3: 30 • Ph2: 201 • 15 sponsors
Cholangiocarcinoma
Ph3: 28 • Ph2: 195 • 15 sponsors
HER2+ Breast Cancer
Ph3: 24 • Ph2: 66 • 15 sponsors
Hodgkin Lymphoma
Ph3: 18 • Ph2: 158 • 15 sponsors
Thyroid Cancer
Ph3: 18 • Ph2: 60 • 15 sponsors
Myelofibrosis
Ph3: 17 • Ph2: 68 • 15 sponsors
HER2- Breast Cancer
Ph3: 15 • Ph2: 76 • 15 sponsors
CML
Ph3: 9 • Ph2: 77 • 15 sponsors
Merkel Cell Carcinoma
Ph3: 4 • Ph2: 36 • 15 sponsors
Mesothelioma
Ph3: 3 • Ph2: 52 • 15 sponsors
Immunology
8934 active trialsRheumatoid Arthritis
Ph3: 884 • Ph2: 2013 • 15 sponsors
Ankylosing Spondylitis
Ph3: 810 • Ph2: 1822 • 15 sponsors
Ulcerative Colitis
Ph3: 110 • Ph2: 255 • 15 sponsors
Lupus
Ph3: 76 • Ph2: 173 • 15 sponsors
Psoriasis
Ph3: 56 • Ph2: 34 • 15 sponsors
Atopic Dermatitis
Ph3: 52 • Ph2: 67 • 15 sponsors
Crohn's Disease
Ph3: 43 • Ph2: 54 • 15 sponsors
Psoriatic Arthritis
Ph3: 23 • Ph2: 13 • 15 sponsors
IBD
Ph3: 8 • Ph2: 27 • 12 sponsors
Cardiovascular
3313 active trialsMyocardial Infarction
Ph3: 389 • Ph2: 754 • 15 sponsors
Stroke
Ph3: 152 • Ph2: 138 • 15 sponsors
Atrial Fibrillation
Ph3: 99 • Ph2: 192 • 15 sponsors
Hypertension
Ph3: 91 • Ph2: 107 • 15 sponsors
Heart Failure
Ph3: 68 • Ph2: 108 • 15 sponsors
Coronary Artery Disease
Ph3: 39 • Ph2: 45 • 15 sponsors
Thrombosis
Ph3: 29 • Ph2: 8 • 6 sponsors
Arrhythmia
Ph3: 10 • Ph2: 11 • 4 sponsors
Hypertrophic Cardiomyopathy
Ph3: 9 • Ph2: 10 • 8 sponsors
CNS
2354 active trialsAlzheimer's Disease
Ph3: 85 • Ph2: 204 • 15 sponsors
Major Depression
Ph3: 76 • Ph2: 177 • 15 sponsors
Multiple Sclerosis
Ph3: 71 • Ph2: 144 • 15 sponsors
Migraine
Ph3: 40 • Ph2: 18 • 13 sponsors
Neuropathy
Ph3: 35 • Ph2: 54 • 15 sponsors
Schizophrenia
Ph3: 33 • Ph2: 39 • 15 sponsors
Epilepsy
Ph3: 33 • Ph2: 35 • 15 sponsors
ALS
Ph3: 29 • Ph2: 69 • 15 sponsors
Opioid Use Disorder
Ph3: 28 • Ph2: 54 • 10 sponsors
Parkinson's Disease
Ph3: 24 • Ph2: 100 • 15 sponsors
Anxiety
Ph3: 24 • Ph2: 49 • 15 sponsors
Alcohol Use Disorder
Ph3: 16 • Ph2: 82 • 10 sponsors
Bipolar Disorder
Ph3: 16 • Ph2: 13 • 8 sponsors
Autism Spectrum Disorder
Ph3: 15 • Ph2: 57 • 12 sponsors
PTSD
Ph3: 11 • Ph2: 45 • 5 sponsors
ADHD
Ph3: 11 • Ph2: 12 • 5 sponsors
Huntington's Disease
Ph3: 4 • Ph2: 15 • 8 sponsors
OCD
Ph3: 2 • Ph2: 15 • 1 sponsors
Metabolic
1430 active trialsObesity
Ph3: 133 • Ph2: 188 • 15 sponsors
Type 2 Diabetes
Ph3: 82 • Ph2: 79 • 15 sponsors
Diabetes (General)
Ph3: 50 • Ph2: 81 • 15 sponsors
Dyslipidemia
Ph3: 34 • Ph2: 28 • 15 sponsors
Diabetic Complications
Ph3: 28 • Ph2: 54 • 15 sponsors
Type 1 Diabetes
Ph3: 26 • Ph2: 69 • 15 sponsors
NASH/NAFLD
Ph3: 21 • Ph2: 62 • 15 sponsors
Infectious Disease
1263 active trialsHIV
Ph3: 72 • Ph2: 124 • 15 sponsors
COVID-19
Ph3: 59 • Ph2: 101 • 15 sponsors
Tuberculosis
Ph3: 42 • Ph2: 44 • 12 sponsors
Influenza
Ph3: 38 • Ph2: 46 • 15 sponsors
Sepsis
Ph3: 31 • Ph2: 47 • 10 sponsors
Hepatitis B
Ph3: 16 • Ph2: 54 • 15 sponsors
Malaria
Ph3: 15 • Ph2: 22 • 8 sponsors
RSV
Ph3: 14 • Ph2: 19 • 15 sponsors
Fungal Infections
Ph3: 13 • Ph2: 14 • 10 sponsors
H. pylori
Ph3: 11 • Ph2: 9 • 2 sponsors
C. difficile
Ph3: 6 • Ph2: 10 • 4 sponsors
Bacterial Infections
Ph3: 4 • Ph2: 8 • 10 sponsors
Hepatitis C
Ph3: 2 • Ph2: 5 • 1 sponsors
Urology
940 active trialsPain
694 active trialsRespiratory
614 active trialsRare Disease
546 active trialsSpinal Muscular Atrophy
Ph3: 37 • Ph2: 89 • 15 sponsors
Immune Thrombocytopenia
Ph3: 36 • Ph2: 85 • 15 sponsors
Hemophilia
Ph3: 34 • Ph2: 19 • 15 sponsors
Sickle Cell Disease
Ph3: 22 • Ph2: 62 • 15 sponsors
Duchenne Muscular Dystrophy
Ph3: 9 • Ph2: 30 • 15 sponsors
Fabry Disease
Ph3: 9 • Ph2: 7 • 10 sponsors
CDKL5 Deficiency Disorder
Ph3: 2 • Ph2: 0 • 2 sponsors
Gaucher Disease
Ph3: 1 • Ph2: 6 • 4 sponsors
Mastocytosis
Ph3: 1 • Ph2: 5 • 4 sponsors
Musculoskeletal
432 active trialsRenal
305 active trialsOphthalmology
259 active trialsGastrointestinal
256 active trialsWomen's Health
187 active trialsDermatology
166 active trialsHepatology
113 active trialsSleep
78 active trialsEndocrine
37 active trialsHot = Crowded space, many late-stage competitors
Cold = Less competition, potential opportunity or difficult indication